Patient 160, despite having the lowest clonal diversity in the entire cohort (i.e. 3 clones identified amongst the three tumor samples profiled), had two independent PIK3CA mutations, including PIK3CAQ546K in A1 and PIK3CAE545K in A2 and A3 (Additional file 2: Fig. S16). This evidence concerns the gene PIK3CA and neoplasm.